Ad(I)-F512-TK administration followed by GCV induced complete tumor remission in all but one mice (5/6) strongly indicating that the presence of HMEC-1 microendothelial cells in the pancreatic tumor mass favored the therapeutic efficacy of Ad-(I)-F512-TK/GCV (Figure 6E). The gene discussed is TKT; the disease is neoplasm.